Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Schollenberger · SciRah

Researcher profile · Semantic Scholar

M. Schollenberger

Share profile

M. Schollenberger — researcher profile on SciRah

h-index: 9
Works: 22
Citations: 588

Most-cited papers

Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation
T. Braaten, J. Brahmer, P. Forde, D. Le +7 more
2019Annals of the Rheumatic Diseases209 citations Open access
Semantic Scholar
Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade
E. Lipson, Mohammed T. Lilo, Aleksandra Ogurtsova, Jessica Esandrio +5 more
2017Journal of Immunotherapy for Cancer137 citations Open access
Semantic Scholar
Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series
J. LoPiccolo, M. Schollenberger, S. Dakhil, S. Rosner +5 more
2019Journal of Immunotherapy for Cancer50 citations Open access
Semantic Scholar
Nivolumab + tacrolimus + prednisone +/− ipilimumab for kidney transplant recipients with advanced cutaneous cancers
K. M. Schenk, J. S. Deutsch, S. Chandra, D. Davar +22 more
2024Journal of Clinical Oncology45 citations Open access
Semantic Scholar
From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real‐world setting
S. Rowe, Brandon S. Luber, Monique Makell, P. Brothers +8 more
2018Molecular Oncology43 citations Open access
Semantic Scholar
Kidney retransplantation after anti-programmed cell death-1 (PD-1)-related allograft rejection
E. Lipson, F. Naqvi, Manisha J. Loss, M. Schollenberger +3 more
2020American Journal of Transplantation25 citations Open access
Semantic Scholar
Immune-mediated ototoxicity associated with immune checkpoint inhibitors in patients with melanoma
S. Rosner, Y. Agrawal, Daniel Q. Sun, N. Aygun +3 more
2020Journal for ImmunoTherapy of Cancer22 citations Open access
Semantic Scholar
Utility of Serial Donor-derived Cell-free DNA Measurements for Detecting Allograft Rejection in a Kidney Transplant Recipient After PD-1 Checkpoint Inhibitor Administration
L. Lakhani, S. Alasfar, Anshul Bhalla, A. Aala +5 more
2021Transplantation Direct18 citations Open access
Semantic Scholar
Anti-RA33 antibodies are present in a subset of patients with immune checkpoint inhibitor-induced inflammatory arthritis
L. Cappelli, C. Bingham, P. Forde, V. Anagnostou +6 more
2021RMD Open16 citations Open access
Semantic Scholar
Immune microenvironment of basal cell carcinoma and tumor regression following combined PD-1/LAG-3 blockade
J. S. Deutsch, Jonathan Lai, K. M. Schenk, Abha Soni +12 more
2023Journal for ImmunoTherapy of Cancer9 citations Open access
Semantic Scholar
Poliosis Circumscripta: A Mark of Melanoma
M. Schollenberger, J. Stein, J. Taube, E. Lipson
2019American Journal of Medicine7 citations Open access
Semantic Scholar
Durable tumor regression and restoration of neurologic function after treatment with anti-PD-1 in patients with functionally unresectable cutaneous squamous cell carcinoma with perineural spread into the cavernous sinus
A. Carey, G. Warrier, J. Hoang, M. Schollenberger +2 more
2023Journal of Neuro-Oncology3 citations Open access
Semantic Scholar
Gut microbiome features associate with immune checkpoint inhibitor response in individuals with non-melanoma skin cancers: an exploratory study
Yu-Jie Zhao, J. Ferri, J. R. White, M. Schollenberger +4 more
2025Microbiology spectrum2 citations Open access
Semantic Scholar
Beyond Checkpoint Inhibition: Keeping Therapeutic Options Open.
U. Joshi, J. Hundal, Jonaphine R. Mata, M. Schollenberger +4 more
2025American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting2 citations Open access
Semantic Scholar
Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus
Juan J Alban, R. C. Bowen, D. Reichstein, M. McKean +46 more
2025Cancers2 citations Open access
Semantic Scholar
Abstract 6469: Longitudinal loss of microbiome stability is associated with poor response to immune checkpoint inhibitors in lung cancer and melanoma
Yujie Zhao, Jarushka Naidoo, Michael Conroy, J. Ferri +17 more
2026Cancer Research0 citations
Semantic Scholar
Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma
J. Smithy, A. Betof, S. Klobuch, T. H. Borch +24 more
2026Journal for ImmunoTherapy of Cancer0 citations Open access
Semantic Scholar
Comparison of baseline gut microbiome features between response subgroups of patients (pts) with advanced melanoma undergoing immune checkpoint inhibitor (ICI) therapy.
M. Ferreira, Kim Peloza, James R. White, M. Schollenberger +4 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Erratum: Beyond Checkpoint Inhibition: Keeping Therapeutic Options Open.
U. Joshi, J. Hundal, Jonaphine R. Mata, M. Schollenberger +4 more
2025American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting0 citations
Semantic Scholar
Primary resistance to ICI-based regimens is associated with early longitudinal changes in the fecal microbiome and loss of microbial stability
Yu-Jie Zhao, J. Naidoo, Michael Conroy, J. Ferri +17 more
2025medRxiv0 citations
Semantic Scholar
695 Phase 2 study of nivolumab and ipilimumab in combination with sirolimus and prednisone in kidney transplant recipients with selected unresectable or metastatic cutaneous cancers
K. M. Schenk, J. S. Deutsch, G. Ansstas, Sunandana Chandra +19 more
2024Regular and Young Investigator Award Abstracts0 citations Open access
Semantic Scholar
Addressing barriers in care management, shared decision-making alignment, and educational needs on novel immunotherapy combinations in melanoma.
T. Ackbarali, Maria Arnone, M. Schollenberger, Omid Hamid +1 more
2023JCO Oncology Practice0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Lipson×13
Invite
E. Lipson — researcher profile on SciRah
W. Sharfman×5
Invite
W. Sharfman — researcher profile on SciRah
Evan J. Lipson×5
Invite
Evan J. Lipson — researcher profile on SciRah
P. Forde×4
Invite
P. Forde — researcher profile on SciRah

×4

Invite

Kim Peloza — researcher profile on SciRah

Invite

J. Naidoo — researcher profile on SciRah

Invite

J. Taube — researcher profile on SciRah

K. M. Schenk×3

Invite

K. M. Schenk — researcher profile on SciRah

J. S. Deutsch×3

Invite

J. S. Deutsch — researcher profile on SciRah

Manisha J. Loss×3

Invite

Manisha J. Loss — researcher profile on SciRah

Invite

J. Ferri — researcher profile on SciRah

Invite

F. Shaikh — researcher profile on SciRah